Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Elanco Animal Health Inc (ELAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,822,648
  • Shares Outstanding, K 365,625
  • Annual Sales, $ 3,067 M
  • Annual Income, $ 86,500 K
  • 36-Month Beta N/A
  • Price/Sales 3.50
  • Price/Cash Flow N/A
  • Price/Book 2.03
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.58
  • Most Recent Earnings 0.29 on 02/06/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.23
  • Number of Estimates 4
  • High Estimate 0.24
  • Low Estimate 0.22
  • Prior Year N/A
  • Growth Rate Est. (year over year) -99.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.00 +5.71%
on 02/06/19
32.02 -7.56%
on 01/18/19
-2.11 (-6.65%)
since 01/15/19
3-Month
28.00 +5.71%
on 02/06/19
34.66 -14.60%
on 12/03/18
-3.49 (-10.55%)
since 11/15/18

Most Recent Stories

More News
Do Options Traders Know Something About Elanco Health (ELAN) Stock We Don't?

Investors need to pay close attention to Elanco Health (ELAN) stock based on the movements in the options market lately.

ELAN : 29.60 (+0.89%)
Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake

Eli Lilly (LLY) to initiate an exchange offer for shareholders to divest its remaining ownership interest in Elanco

ELAN : 29.60 (+0.89%)
LLY : 122.48 (+1.43%)
ZTS : 95.37 (+2.26%)
PFE : 42.40 (+1.02%)
Elanco Animal Health to File Registration Statement in Connection With Lilly Divestiture Announcement

Elanco Animal Health Incorporated (NYSE: ELAN), formerly the animal health business of Eli Lilly and Company (Lilly), today announced it intends to file a Form S-4 Registration Statement...

ELAN : 29.60 (+0.89%)
LLY : 122.48 (+1.43%)
Lilly Will Initiate Divestiture of its Remaining Interest in Elanco Animal Health

Eli Lilly and Company (NYSE: LLY) announced it will initiate an exchange offer today to divest its remaining interest in Elanco Animal Health (NYSE: ELAN).

ELAN : 29.60 (+0.89%)
LLY : 122.48 (+1.43%)
Eli Lilly (LLY) Q4 Earnings Coming Up: What's in the Cards?

Eli Lilly and Company's (LLY) new drugs like Trulicity, Taltz and Jardiance are performing well. Let's see if these along with its older products lead the company to an earnings beat.

ELAN : 29.60 (+0.89%)
NVO : 50.35 (+1.15%)
MRK : 79.81 (+1.10%)
LLY : 122.48 (+1.43%)
The Zacks Analyst Blog Highlights: Intuitive Surgical, Illumina, HCA, Elanco Animal and Humana

The Zacks Analyst Blog Highlights: Intuitive Surgical, Illumina, HCA, Elanco Animal and Humana

HUM : 310.30 (+2.90%)
ELAN : 29.60 (+0.89%)
ILMN : 299.82 (+2.51%)
HCA : 144.26 (+1.43%)
ISRG : 548.50 (+2.32%)
5 Great Medical Stocks to Buy Ahead of Q4 Earnings

A Reuters review of Wall Street Research firms reveals that health care is the most favored of the S&P 500's 11 major sectors.

HUM : 310.30 (+2.90%)
ELAN : 29.60 (+0.89%)
ILMN : 299.82 (+2.51%)
HCA : 144.26 (+1.43%)
ISRG : 548.50 (+2.32%)
CORRECTING and REPLACING The NYSE Welcomes 2019 as the Global Leader in Listings

--Each of the last 25 consecutive U.S. IPOs raising $1 billion or more listed on the NYSE;

BE : 11.31 (-3.25%)
REZI : 25.41 (+2.05%)
CDAY : 45.76 (+0.35%)
BJ : 25.86 (+0.04%)
VNE : 29.00 (+4.09%)
NTR : 53.44 (-0.72%)
NVT : 26.95 (+2.20%)
FPAC : 9.80 (-0.41%)
ADT : 8.05 (+1.26%)
WH : 51.85 (+1.67%)
FTCH : 19.60 (+3.16%)
HUD : 13.88 (-0.07%)
QGEN : 38.64 (+1.18%)
PVTL : 21.16 (+4.65%)
EQH : 19.34 (+3.20%)
EB : 30.88 (-2.28%)
DELL : 55.00 (+1.14%)
CCC : 11.54 (+0.26%)
SPOT : 148.52 (+1.12%)
SWI : 19.02 (+1.71%)
YETI : 22.84 (+4.29%)
ARLO : 3.68 (-2.13%)
ICE : 75.50 (-0.59%)
SPAQ : 9.79 (-0.10%)
AMRX : 13.74 (+3.78%)
SMAR : 37.07 (+1.23%)
TME : 16.17 (-4.83%)
LTHM : 12.85 (+2.64%)
LIN : 168.54 (+1.23%)
VICI : 21.38 (-1.29%)
GSAH : 9.89 (-0.40%)
ELAN : 29.60 (+0.89%)
RAMP : 52.64 (+1.09%)
ZUO : 22.50 (-0.04%)
HUYA : 19.44 (-1.82%)
PAGS : 23.59 (+0.90%)
SUZ : 24.18 (+0.75%)
TAK : 20.46 (+1.74%)
The NYSE Welcomes 2019 as the Global Leader in Listings

--Each of the last 25 consecutive U.S. IPOs raising $1 billion or more listed on the NYSE;

BE : 11.31 (-3.25%)
REZI : 25.41 (+2.05%)
CDAY : 45.76 (+0.35%)
BJ : 25.86 (+0.04%)
VNE : 29.00 (+4.09%)
NTR : 53.44 (-0.72%)
NVT : 26.95 (+2.20%)
FPAC : 9.80 (-0.41%)
ADT : 8.05 (+1.26%)
WH : 51.85 (+1.67%)
FTCH : 19.60 (+3.16%)
HUD : 13.88 (-0.07%)
QGEN : 38.64 (+1.18%)
PVTL : 21.16 (+4.65%)
EB : 30.88 (-2.28%)
DELL : 55.00 (+1.14%)
CCC : 11.54 (+0.26%)
SPOT : 148.52 (+1.12%)
SWI : 19.02 (+1.71%)
YETI : 22.84 (+4.29%)
ARLO : 3.68 (-2.13%)
ICE : 75.50 (-0.59%)
SPAQ : 9.79 (-0.10%)
AMRX : 13.74 (+3.78%)
SMAR : 37.07 (+1.23%)
TME : 16.17 (-4.83%)
LTHM : 12.85 (+2.64%)
LIN : 168.54 (+1.23%)
VICI : 21.38 (-1.29%)
GSAH : 9.89 (-0.40%)
ELAN : 29.60 (+0.89%)
RAMP : 52.64 (+1.09%)
ZUO : 22.50 (-0.04%)
HUYA : 19.44 (-1.82%)
PAGS : 23.59 (+0.90%)
SUZ : 24.18 (+0.75%)
TAK : 20.46 (+1.74%)
Lilly's Shares Rise on Robust 2019 View, Dividend Hike

Eli Lilly's (LLY) shares rise 3% on an upbeat outlook for 2019. It also hikes quarterly dividend by 15%.

ELAN : 29.60 (+0.89%)
LLY : 122.48 (+1.43%)
TEVA : 17.98 (+4.05%)
AMGN : 188.34 (+0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ELAN with:

Business Summary

Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.

See More

Key Turning Points

2nd Resistance Point 30.05
1st Resistance Point 29.83
Last Price 29.60
1st Support Level 29.29
2nd Support Level 28.97

See More

52-Week High 37.61
Fibonacci 61.8% 33.94
Fibonacci 50% 32.81
Fibonacci 38.2% 31.67
Last Price 29.60
52-Week Low 28.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar